Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2024400563-A1 · Dec 5, 2024 · US
This page is not indexed by search engines while we improve data quality.
Dasgupta Bireshwar patents
Dasgupta Bireshwar is listed as an inventor on 25 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dasgupta Bireshwar |
| Total patents | 25 |
| First publication | May 14, 2015 |
| Latest publication | Dec 5, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination of a t cell therapy and a dgk inhibitor
US-2024108654-A1 · Apr 4, 2024 · US
Substituted naphthyridinone compounds useful as T cell activators
US-11713316-B2 · Aug 1, 2023 · US
Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2023151007-A1 · May 18, 2023 · US
Combinations of dgk inhibitors and checkpoint antagonists
US-2023089255-A1 · Mar 23, 2023 · US
Substituted pyridopyrimidinonyl compounds useful as T cell activators
US-11584747-B2 · Feb 21, 2023 · US
Substituted naphthyridinone compounds useful as t cell activators
US-2022324859-A1 · Oct 13, 2022 · US
Isofuranone compounds useful as HPK1 inhibitors
US-11166959-B2 · Nov 9, 2021 · US
Substituted naphthyridinone compounds useful as T cell activators
US-10954238-B1 · Mar 23, 2021 · US
Substituted pyridopyrimidinonyl compounds useful as t cell activators
US-2021061802-A1 · Mar 4, 2021 · US
Recent patents
Latest publications not already listed above.
Isofuranone compounds useful as hpk1 inhibitors
US-2020390776-A1 · Dec 17, 2020 · US
Substituted naphthyridinone compounds useful as T cell activators
US-10669272-B2 · Jun 2, 2020 · US
Substituted naphthyridinone compounds useful as t cell activators
US-2020109140-A1 · Apr 9, 2020 · US
Heterocyclic kinase inhibitors
US-10035777-B2 · Jul 31, 2018 · US
Quinoline-based kinase inhibitors
US-9932320-B2 · Apr 3, 2018 · US
Heterocyclic kinase inhibitors
US-2017260145-A1 · Sep 14, 2017 · US
Quinazoline-based kinase inhibitors
US-2017239249-A1 · Aug 24, 2017 · US
Pyrrolotriazine kinase inhibitors
US-9737542-B2 · Aug 22, 2017 · US
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
US-9598423-B2 · Mar 21, 2017 · US
Quinoline-Based Kinase Inhibitors
US-2016332985-A1 · Nov 17, 2016 · US
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine derivatives as casein kinase 1 d/e inhibitors
US-2016311824-A1 · Oct 27, 2016 · US
Pyrrolotriazine kinase inhibitors
US-2016243125-A1 · Aug 25, 2016 · US
Novel substituted pyrazolo-piperazines as casein kinase 1 d/e inhibitors
US-2016122358-A1 · May 5, 2016 · US
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
US-9273058-B2 · Mar 1, 2016 · US
Novel substituted pyrazolo-piperazines as casein kinase 1 d/e inhibitors
US-2015133428-A1 · May 14, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 24 |
| Bristol-Meyers Squibb Company | 1 |
| Juno Therapeutics Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 18 |
| C07D471/04 | 13 |
| A61P31/12 | 11 |
| A61P43/00 | 11 |
| A61P25/00 | 10 |